Prescient Therapeutics Ltd

PTX

Company Profile

  • Business description

    Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.

  • Contact

    Level 4, 100 Albert Road
    South Melbourne
    MelbourneVIC3205
    AUS

    T: +61 396927222

    https://www.ptxtherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    12

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,640.0015.100.18%
CAC 407,788.1038.69-0.49%
DAX 4024,038.19188.30-0.78%
Dow JONES (US)42,098.70244.95-0.58%
FTSE 1008,726.0152.04-0.59%
HKSE23,408.36150.050.65%
NASDAQ19,100.9498.22-0.51%
Nikkei 22538,327.91605.511.61%
NZX 50 Index12,288.7073.56-0.60%
S&P 5005,888.5532.99-0.56%
S&P/ASX 2008,413.5016.600.20%
SSE Composite Index3,363.9724.040.72%

Market Movers